Li et al. reported that NAFLD was improved in HFD-fed mice treated with anti-TNF antibodies [34], indicating that the drugs, which can inhibit inflammatory response, may be beneficial for NAFLD. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.